RGCC is a leading-edge form of precision medicine that analyzes the unique genetic and biological characteristics of a patient's condition. Rather than relying on one-size-fits-all treatment pathways, RGCC uses a simple blood draw to isolate circulating tumor cells or viral markers and examine their gene expression, behavior, vulnerabilities, and response to various therapeutic agents.
For cancer patients, this creates an individual cancer profile that can detect early transformation, monitor existing disease, and track potential metastasis. For chronic viral infection patients, it maps the specific genetic sequences driving persistent infections. In both cases, RGCC identifies which targeted therapies are most effective for your specific condition.
1. Oncology Patients
For patients with a cancer diagnosis — or those who want proactive early detection. RGCC analyzes your circulating tumor cells to map drug sensitivities, monitor treatment response, and guide personalized therapy selection.
Active cancer diagnosis; Cancer monitoring; Early detection screening; Recurrence prevention.
2. Chronic Viral Infection Patients
For patients dealing with persistent viral conditions that conventional treatments haven't resolved. RGCC's PrimeSpot testing identifies your specific viral signatures, and Q-REstrain gene-silencing therapy targets them at the genetic level.
Epstein-Barr (EBV); Lyme disease; Chronic viral reactivation; Co-infections.
.jpg)
1. Clavic-Q-RE (aka. VAXO-Q-RE)
Clavic-Q-RE is classified as a Cell Therapy Medicinal Product (CTMP) by the European Medicines Agency and is currently in clinical trials. It is a personalized cellular immunotherapy composed of five types of your own immune cells:
2. SOT (aka.Q-REstrain)
Q-REstrain is a supportive therapy based on microRNA molecules isolated from your own blood, designed to target and silence the specific genes driving your cancer or chronic condition. By degrading the messenger RNA responsible for disease progression, Q-REstrain works with your body's natural regulatory processes to suppress the proteins that allow disease to advance. This approach — known as RNA interference — is one of the most promising frontiers in personalized medicine today.
.jpg)
Our lead physician, Dr. Biljana Kostovic, is a leader in RGCC diagnostics and therapies in Canada. She has been recognized by RGCC international as a pioneer in the field, pushing the boundaries of precision medicine. With specialties in Emergency Medicine and Pain Medicine, she brings a rare combination of rapid-response and long-term care to her practice. A former department head in Charlotte County, New Brunswick, Dr. Kostovic brings institutional leadership and clinical excellence in equal measure.
At Upper Room Clinic, we offer advanced RGCC testing to help patients better understand their cancer at a genetic and cellular level. This cutting-edge blood test analyzes circulating tumor cells, immune response, and genetic expression to reveal how your cancer behaves and which treatments may be most effective for your unique case.
Through our integrative approach in Toronto and Oakville, RGCC testing becomes the foundation for a personalized care plan—supporting early detection, treatment optimization, and ongoing monitoring so you can make informed decisions about your health with confidence.
Contact Us
Locations
Upper Room Clinic – Oakville
Tel: 647-910-5359
Fax: 289-644-0255
oakville@upperroomclinic.com
Upper Room Clinic – Davisville
Tel: 647-521-8024
Fax: 647-348-8024
hello@upperroomclinic.com
Tuesday to Saturday
11am-6pm
Stay connected
Sign up to receive updates, offers, and the latest news directly to your inbox.
Copyright © 2026 Upper Room Clinic | Privacy Policy | Terms of Use
